Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Promising Phase 2 Results for Novel Oral Alzheimer's DrugAn investigational dual PPAR agonist modifies Alzheimer's pathology and shows cognitive
benefit in adults with mild-to-moderate disease and high plasma pTau-217 ratio, early
data show.
Medscape Medical News, Oct 25, 2023
Natural Killer Cell Therapy Shows Promise in Alzheimer'sData from a small phase I study show significant clinical and biomarker activity of
an investigational natural killer cell therapy in adults with AD, prompting a larger
phase 2 trial.
